TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally. The company operates through Oncology Business Unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business Unit, Other Business Unit, and Re-investment Business Unit segments. It offers oncology drugs for the treatment of anticancer and adjunctive therapies under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, …
Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
18,922,260,480
Fair value reference
70.80
Next-week expectancy
Undecided · 48.79%
Executive chart read
Over the latest 12 completed weeks ending 2026-08-14, 4105 rose 3.68%, moving from 73.40 to 76.10. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -28.78 and has improved across the 12-week window. Market Dynamics is 0.40 on the latest week. Next-week expectancy is undecided at 48.79% based on similar historical setup states.
Week Ending
14 Aug 2026
Latest Close
76.10
12-Week Change
3.68%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 48.79%
Signal Weeks
0 of 12
Weekly Price
Weekly Close
Trend Line
Fair Value
Activity Lines
Chart Panels
Choose up to 5 panels. Drag panel headers to reorder.
Price Action
Up Week
Down Week
Trend Line
Pivotal Level / Support
Volume
Range
Sharemaestro Range
Where price is trading
The fitted range, accepted trading area and strongest price levels are calculated automatically from completed weekly market data.
Current stateInside accepted value
52-week position
46.5%
Low to high
Accepted price
74.50
Latest versus accepted: 2.15%
Fitted direction
Sideways
0.05% per week
Range pressure
48/100
Balanced pressure
Range condition
Expanding
1.37× normal range
Range pressureCurrent range pressure · 50 is balanced
Weekly closeFitted rangeActivity ribbonEstimated activity at priceAutomatic level
Automatic structure
Strongest price levels
Support71.06
From price
-6.6%
Evidence
89/100
Touches
5
Support74.50
From price
-2.1%
Evidence
100/100
Touches
5
Current pivot76.09
From price
0.0%
Evidence
84/100
Touches
4
Resistance78.11
From price
2.7%
Evidence
64/100
Touches
2
Resistance79.50
From price
4.5%
Evidence
51/100
Touches
2
Current reading
What the range shows
Current positionInside accepted value
Price is at 46.5% of its latest 52-week range.
Fitted directionSideways
The fitted centre line is moving +0.05% per week.
Range pressureBalanced pressure
The current pressure reading is 48/100; 50 is balanced.
Next structural level78.11
Resistance is 2.6% from the latest close with 64/100 evidence strength.
Point & Figure
Price structure · volume at price
Point & Figure market structure
Each X marks a rising price box and each O marks a falling price box. Time is removed from the horizontal scale so reversals, breakouts and areas of heavy trading stand out.
MethodAdaptive scale
Smart Money
Close Price
Trend Line
Demand Threshold Line
Reversal Risk Level
Market Dynamics
Volume Action
Price Action
Market Dynamics
Rate of Change
0-1.5TopBottomRawCloseMarket Strength30W ROCVolume SupportPrice Action RibbonBuyFlip UpFlip Down
Price Cycle
Market Price Cycle
PC Activity Line
PC Trend Line
Next-State Map
Next-State Map
Historical one-week transition paths from similar completed-week states.
SMI
Weekly Close
Trend Line
Fair Value
Activity Lines
SMI
Chart Summary
Key Points
Week Ending
14 Aug 2026
Latest Close
76.10
12-Week Change
3.68%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 48.79%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-28.78
Market Dynamics
0.40
Over the latest 12 completed weeks ending 2026-08-14, 4105 rose 3.68%, moving from 73.40 to 76.10. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -28.78 and has improved across the 12-week window. Market Dynamics is 0.40 on the latest week. Next-week expectancy is undecided at 48.79% based on similar historical setup states.
Industry Peers
Taiwan equities in Drug Manufacturers - Specialty & Generic
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.
